Capstone Therapeutics Corp (CAPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,230 | -2,563 | -3,819 | -380 | -1,755 |
| Depreciation Amortization | 2,564 | 310 | 461 | 157 | 205 |
| Income taxes - deferred | 7,178 | 419 | 32 | N/A | N/A |
| Accounts receivable | 292 | -181 | 3,920 | N/A | N/A |
| Accounts payable and accrued liabilities | 83 | 624 | 235 | 48 | -52 |
| Other Working Capital | 1,619 | 5,702 | 4,176 | 36 | -79 |
| Other Operating Activity | 5,082 | -443 | -3,355 | 205 | 120 |
| Operating Cash Flow | $-4,412 | $3,868 | $1,650 | $66 | $-1,561 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -122 | -120 | -208 | N/A | N/A |
| Net Acquisitions | -6,753 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -38 | -66 | N/A | N/A | N/A |
| Other Investing Activity | -38 | -66 | 0 | 0 | 0 |
| Investing Cash Flow | $-6,913 | $-186 | $-208 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,315 | -2,315 | 1,303 | N/A | 2,140 |
| Debt Repayment | -1,143 | -1,208 | -2,315 | N/A | -1,000 |
| Common Stock Issued | 5,030 | N/A | N/A | N/A | 1,013 |
| Other Financing Activity | 3,915 | -200 | -401 | 0 | -15 |
| Financing Cash Flow | $12,117 | $-3,723 | $-1,413 | $N/A | $2,138 |
| Exchange Rate Effect | -76 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 11 | 52 | 23 | 1,275 | 698 |
| End Cash Position | 727 | 11 | 52 | 1,341 | 1,275 |
| Net Cash Flow | $716 | $-41 | $29 | $66 | $577 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,412 | 3,868 | 1,650 | 66 | -1,561 |
| Capital Expenditure | -122 | -120 | -208 | N/A | N/A |
| Free Cash Flow | -4,534 | 3,748 | 1,442 | 66 | -1,561 |